Fostair 200/6 inhalation solution

Država: Velika Britanija

Jezik: engleski

Izvor: myHealthbox

Kupi sada

Uputa o lijeku Uputa o lijeku (PIL)
26-05-2024
Svojstava lijeka Svojstava lijeka (SPC)
26-05-2024

Aktivni sastojci:

beclometasone dipropionate, formoterol fumarate dihydrate.

Dostupno od:

Chiesi Limited

ATC koda:

R03AK08

INN (International ime):

beclometasone dipropionate, formoterol fumarate dihydrate.

Doziranje:

200/6 micrograms/metered dose

Farmaceutski oblik:

Pressurised inhalation solution.

Administracija rute:

inhalation use.

Jedinice u paketu:

1 or 2 pressurised container which provides 120 actuations

Tip recepta:

POM - Prescription Only Medicine

Proizveden od:

Chiesi Farmaceutici

Terapijska grupa:

Drugs for obstructive airway diseases; Adrenergics, inhalants

Terapijske indikacije:

Fostair is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists. Fostair is indicated in adults.

Status autorizacije:

Authorised

Datum autorizacije:

2015-12-03

Uputa o lijeku

                                Package Leaflet: Information for the user
_200/6 MICROGRAMS PER ACTUATION PRESSURISED INHALATION SOLUTION_
_BECLOMETASONE DIPROPIONATE/ FORMOTEROL FUMARATE DIHYDRATE_
For use in adults.
PAG. 1/2
0108000870/01
1
2
3
4
FONTS: MetaPlus
CORPO: 9,5 pt
(5) 
CODICE DI RIFERIMENTO 00783/R
REPARTO:
LINEA: 
CHIESI FARMACEUTICI 
S.P.A.
 - PARMA - ITALIA
VIETATA LA MANOMISSIONE
D.Q.O.C. - UFFICIO GRAFICO
AUTORE: MS/Tipocrom
mail: 
m.sigurani@chiesi.com
(1) DESCRIZIONE MATERIALE
DIMENSIONI FOGLIO STESO
540 x 300 mm
(4) CODICE
0108000870/01
(8) DATA A.A.
05/05/2015
(2) F.TO A.A.
F065
(3) 
N˚ PHARMACODE 864 (COD. A BARRE)
DIMENSIONI FOGLIO FINITO PIEGATO
180 x 38 mm
COLORI DI STAMPA N° 1
FUSTELLA
F.E.FOSTAIR 200/6 MCG MDI CH. LTD
(7) 
Rif. richiesta di codifica del 11/05/2015 - 
(6) 
Motivo: 
- Regolatorio:  Launch new product presentation
- Tecnico:
TOT. PAG. PDF: N. 2
Language: English
BIANCA
NERO+retini
TECHNICAL INFORMATION / INFORMAZIONI TECNICHE
DEFINITIVO:         PDF per il fornitore e per Chiesi Farm. 
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS 
IMPORTANT INFORMATION FOR YOU.
 - Keep this leaflet. You may need to read it again.
 - If you have any further questions, ask your doctor, pharmacist or
nurse.
 - This medicine has been prescribed for you only. Do not pass it on
to others. It may harm them, even if their 
signs of illness are the same as yours.
 - If you get any side effects talk with your doctor, pharmacist or
nurse. This includes any possible side 
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.  What Fostair is and what it is used for
2. What you need to know before you use Fostair
3. How to use Fostair
4. Possible side effects
5. How to store Fostair
6. Contents of the pack and other information
1. WHAT FOSTAIR IS AND WHAT IT IS USED FOR
Fostair is a pressurised inhalation solution containing two active
substances which are inhaled through your 
mouth and delivered directly into
                                
                                Pročitajte cijeli dokument
                                
                            

Svojstava lijeka

                                )RVWDLULQKDODWLRQVROXWLRQ
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG'HF_&KLHVL/LPLWHG
1DPHRIWKHPHGLFLQDOSURGXFW
)RVWDLUPLFURJUDPVSHUDFWXDWLRQSUHVVXULVHGLQKDODWLRQVROXWLRQ
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
(DFKPHWHUHGGRVHH[YDOYHFRQWDLQV
PLFURJUDPVRIEHFORPHWDVRQHGLSURSLRQDWHDQGPLFURJUDPVRIIRUPRWHUROIXPDUDWHGLK\GUDWH7KLVLVHTXLYDOHQW
WRDGHOLYHUHGGRVHH[DFWXDWRURIPLFURJUDPVRIEHFORPHWDVRQHGLSURSLRQDWHDQGPLFURJUDPVRIIRUPRWHURO
IXPDUDWHGLK\GUDWH
)RUWKHIXOOOLVWRIH[FLSLHQWVVHHVHFWLRQ
3KDUPDFHXWLFDOIRUP
3UHVVXULVHGLQKDODWLRQVROXWLRQ
7KHFDQLVWHUFRQWDLQVDFRORXUOHVVWR\HOORZLVKVROXWLRQ
7KHFDQLVWHUVDUHILWWHGLQWRDSODVWLFDFWXDWRULQFRUSRUDWLQJDPRXWKSLHFHDQGILWWHGZLWKDGXVWFDS
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
)RVWDLULVLQGLFDWHGLQWKHUHJXODUWUHDWPHQWRIDVWKPDZKHUHXVHRIDFRPELQDWLRQSURGXFWLQKDOHGFRUWLFRVWHURLGDQG
ORQJDFWLQJEHWD

DJRQLVWLVDSSURSULDWH
SDWLHQWVQRWDGHTXDWHO\FRQWUROOHGZLWKLQKDOHGFRUWLFRVWHURLGVDQG
DVQHHGHG LQKDOHGUDSLGDFWLQJEHWD

DJRQLVWRU
SDWLHQWVDOUHDG\DGHTXDWHO\FRQWUROOHGRQERWKLQKDOHGFRUWLFRVWHURLGVDQGORQJDFWLQJEHWD

DJRQLVWV
)RVWDLULVLQGLFDWHGLQDGXOWV
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
3RVRORJ\
)RVWDLULVQRWLQWHQGHGIRUWKHLQLWLDOPDQDJHPHQWRIDVWKPD7KHGRVDJHRIWKHFRPSRQHQWVRI)RVWDLULVLQGLYLGXDODQG
VKRXOGEHDGMXVWHGWRWKHVHYHULW\RIWKHGLVHDVH7KLVVKRXOGEHFRQVLGHUHGQRWRQO\ZKHQWUHDWPHQWZLWKFRPELQDWLRQ
SURGXFWVLVLQLWLDWHGEXWDOVRZKHQWKHGRVHLVDGMXVWHG,IDQLQGLYLGXDOSDWLHQWVKRXOGUHTXLUHDFRPELQDWLRQRIGRVHV
RWKHUWKDQWKRVHDYDLODEOHLQWKHFRPELQDWLRQLQKDOHUDSSURSULDWHGRVHVRIEHWD

DJRQLVWVDQGRUFRUWLFRVWHURLGVE\
LQGLYLGXDOLQKDOHUVVKRXOGEHSUHVFULEHG
%HFORPHWDVRQHGLSURSLRQDWHLQ)RVWDLULVFKDUDFWHULVHGE\DQH[WUDILQHSDUWLFOHVL]HGLVWULEXWLRQZKLFKUHVXOWVLQDPRUH
SRWHQWHIIHFWWKDQIRUPXODWLRQVRIEHFORPHWDVRQHGLSURSLRQDWHZLW
                                
                                Pročitajte cijeli dokument